title: Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
abstract: Glucagon, the counter-regulatory hormone to insulin, is secreted from pancreatic alpha cells in response to low blood glucose. To examine the role of glucagon in glucose homeostasis, mice were generated with a null mutation of the glucagon receptor (Gcgr(-/-)). These mice display lower blood glucose levels throughout the day and improved glucose tolerance but similar insulin levels compared with control animals. Gcgr(-/-) mice displayed supraphysiological glucagon levels associated with postnatal enlargement of the pancreas and hyperplasia of islets due predominantly to alpha cell, and to a lesser extent, delta cell proliferation. In addition, increased proglucagon expression and processing resulted in increased pancreatic glucogen-like peptide 1 (GLP-1) (1-37) and GLP-1 amide (1-36 amide) content and a 3- to 10-fold increase in circulating GLP-1 amide. Gcgr(-/-) mice also displayed reduced adiposity and leptin levels but normal body weight, food intake, and energy expenditure. These data indicate that glucagon is essential for maintenance of normal glycemia and postnatal regulation of islet and alpha and delta cell numbers. Furthermore, the lean phenotype of Gcgr(-/-) mice suggests glucagon action may be involved in the regulation of whole body composition.
authors.affiliation: Department of Diabetes Biology, Pharmacological Research 2, Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark.
authors.forename: R W
authors.initials: RW
authors.lastname: Gelling
authors.forename: X Q
authors.initials: XQ
authors.lastname: Du
authors.forename: D S
authors.initials: DS
authors.lastname: Dichmann
authors.forename: J
authors.initials: J
authors.lastname: Romer
authors.forename: H
authors.initials: H
authors.lastname: Huang
authors.forename: L
authors.initials: L
authors.lastname: Cui
authors.forename: S
authors.initials: S
authors.lastname: Obici
authors.forename: B
authors.initials: B
authors.lastname: Tang
authors.forename: J J
authors.initials: JJ
authors.lastname: Holst
authors.forename: C
authors.initials: C
authors.lastname: Fledelius
authors.forename: P B
authors.initials: PB
authors.lastname: Johansen
authors.forename: L
authors.initials: L
authors.lastname: Rossetti
authors.forename: L A
authors.initials: LA
authors.lastname: Jelicks
authors.forename: P
authors.initials: P
authors.lastname: Serup
authors.forename: E
authors.initials: E
authors.lastname: Nishimura
authors.forename: M J
authors.initials: MJ
authors.lastname: Charron
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001835:Body Weight; D002151:Calorimetry; D002455:Cell Division; D000242:Cyclic AMP / Q000378:metabolism; D004822:Epididymis / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000378:metabolism; D006728:Hormones / Q000378:metabolism; D006965:Hyperplasia; D007150:Immunohistochemistry; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000473:pathology*; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008856:Microscopy, Fluorescence; D010641:Phenotype; D018027:Receptors, Glucagon / Q000235:genetics* / Q000502:physiology*; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D006728:Hormones; D007328:Insulin; D018027:Receptors, Glucagon; D005934:Glucagon; D000242:Cyclic AMP; D005947:Glucose; D004837:Epinephrine